Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen

Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen Uses, Dosage, Side Effects, Food Interaction and all others data.

Neisseria meningitidis serogroup B recombinant lp2086 a05 protein variant antigen is a sterile vaccine for intramuscular injection indicated for the active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. It is contained in the suspension of Trumenba, which is a vaccine is composed of two recombinant lipidated factor H binding protein (fHBP) variants from N. meningitidis serogroup B, one from fHBP subfamily A and one from subfamily B (A05 and B01, respectively).

Trade Name Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen
Generic Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen
Type
Groups Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen
Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen

Innovators Monograph

You find simplified version here Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen

*** Taking medicines without doctor's advice can cause long-term problems.
Share